Cancer as a mitochondrial disease
Seyfried argues cancer begins with damage to mitochondria rather than primarily from genetic mutations. He says impaired cellular energy metabolism is the root driver of tumor behavior.
Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!
Source description
1,700 Americans will die from cancer today. 70 every single hour. Professor Thomas Seyfried says it doesn't have to be this way, and that mainstream oncology has misunderstood cancer for 100 years. Thomas Seyfried, PhD, is a professor of biology at Boston College and one of the …
1,700 Americans will die from cancer today. 70 every single hour. Professor Thomas Seyfried says it doesn't have to be this way, and that mainstream oncology has misunderstood cancer for 100 years. Thomas Seyfried, PhD, is a professor of biology at Boston College and one of the world's leading researchers on the metabolic origins of cancer. He is author of the book 'Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer' and co-developer of the Glucose Ketone Index (GKI) and the “press-pulse” therapeutic strategy. He explains: ◼ Why he believes cancer is a mitochondrial metabolic disease, not a genetic one ◼ Why cancer cells feed on two fuels and the strategy his team uses to starve tumors ◼ How a ketogenic diet could lower your GKI and make chemo and immunotherapy work better ◼ The environmental drivers quietly damaging your mitochondria ◼ How his team is keeping glioblastoma patients alive for years, and why almost no patient is ever told this option exists The views expressed are those of the guest, and this conversation is intended for general informational purposes only. This podcast and its associated materials should not be used as a substitute for professional medical advice, diagnosis, or treatment. Chapters 00:00:00 Intro 00:02:22 The New Discovery About Cancer 00:03:23 What Role Do Mitochondria Play in Cancer? 00:07:52 ATP & Fermentation: How Your Cells Make Energy 00:14:40 The Oncogenic Paradox Finally Explained 00:19:59 Ghost Mitochondria: Cancer Under the Microscope 00:24:59 Glucose & Glutamine: The Fuels That Feed Cancer 00:26:12 Why Do Children & Babies Get Cancer? 00:29:05 Why Wealthy Countries Have More Cancer 00:32:35 Is Cancer Genetic? 00:37:38 The Prescription: The Glucose Ketone Index 00:40:03 How Stress & Poor Sleep Fuel Cancer 00:44:34 What's Inside the Confidential Envelope? 00:45:38 The Patient Who Inspired the Discovery 00:50:05 Measuring Your Glucose Ketone Index Live 00:52:41 The 'Red Zone' Link To Cancer 00:57:42 The Man Who Survived Glioblastoma for 10 Years 00:58:35 Using the Keto Diet to Supercharge Chemo 01:07:12 The Experiment That Could Prove Cancer Isn't Genetic 01:08:10 1,700 Cancer Deaths a Day: Seyfried's Warning 01:13:21 Seyfried's Plan to End the Cancer Epidemic 01:16:05 What Foods You Should Actually Eat 01:21:38 Fasting Protocols & Hitting 'The Wall' 01:26:28 Hyperbaric Oxygen Therapy & Cancer 01:28:10 Microplastics & 'Forever Chemicals' 01:30:27 How Cancer Spreads: Metastasis Explained 01:37:07 The #1 Actionable Takeaway 01:39:25 Energy, Hope & Final Words Follow Professor Thomas: ◼Instagram - https://link.thediaryofaceo.com/1MRuOwr ◼X - https://link.thediaryofaceo.com/DDF9xxr ◼Substack - https://link.thediaryofaceo.com/HKsGFcF ◼ Professor Seyfried's Biology Department - https://link.thediaryofaceo.com/HKwWhwD ◼ Foundation for Cancer Metabolic Therapies - https://link.thediaryofaceo.com/6Ehj3Hh ◼ Elizabeth Ann Weathers Breast Cancer Research Fund - https://link.thediaryofaceo.com/Bf10aHy A message from Professor Seyfried: “If you would like to support research on the mitochondrial metabolic theory of cancer, please consider donating to our research. Please remember that no donation amount is too small or too large.” The Diary Of A CEO: ◼ Join DOAC circle here - https://doaccircle.com/ ◼ Buy The Diary Of A CEO book here - https://smarturl.it/DOACbook ◼ The 1% Diary is back - limited time only: https://bit.ly/3YFbJbt ◼ The Diary Of A CEO Conversation Cards: https://linkly.link/2hm7r ◼ Get email updates - https://bit.ly/diary-of-a-ceo-yt ◼ Follow Steven - https://g2ul0.app.link/gnGqL4IsKKb
Key Topics
- Cancer as a mitochondrial disease
- Role of mitochondria in health
- How mitochondrial damage happens
- Fermentation as cancer's fallback
- Glucose and glutamine as key fuels
- Warburg theory revisited
- Mutations as downstream effects
- Critique of mainstream oncology
- Cancer risk in modern environments
- Mitochondria-centered prevention
- Prevention and risk zones
- Ketosis and metabolic therapy
- Need to target glutamine too
- Combining metabolism with standard care
- Metastasis and hybrid cells
- Fasting and fasting-mimicking approaches
- Hyperbaric oxygen synergy
- Concerns about cachexia and keto
- Environmental toxins and policy ideas
- Patient self-advocacy
- Hope through longer-term management
Role of mitochondria in health
As context, mitochondria are described as the cell's energy system and a regulator of cell behavior. He says their condition influences aging, resilience, and disease risk across the body.
How mitochondrial damage happens
He links chronic mitochondrial injury to carcinogens, inflammation, intermittent hypoxia, poor sleep, inactivity, stress, and toxic exposures. In his view, these repeated insults gradually disrupt normal energy production.
Fermentation as cancer's fallback
When mitochondria are impaired, he says cells compensate by switching toward ancient fermentation pathways. This shift lets cells keep generating energy, but in a less efficient way associated with uncontrolled growth.
Glucose and glutamine as key fuels
He presents glucose and glutamine as the two main fuels sustaining cancer growth. Because fermentation is inefficient, he says cancer cells become highly dependent on a large supply of both.
Warburg theory revisited
Drawing on Otto Warburg's work, Seyfried says cancer cells ferment even when oxygen is present because their mitochondria are functionally damaged. He argues modern evidence supports that metabolic interpretation.
Mutations as downstream effects
He challenges the standard view that mutations are the primary cause of cancer. Instead, he frames many DNA changes as downstream consequences of mitochondrial dysfunction and oxidative stress.
Critique of mainstream oncology
Seyfried argues oncology remains too focused on genetics and cell division while overlooking metabolism. He says this limits treatment strategy and slows adoption of metabolic approaches.
Cancer risk in modern environments
He contrasts traditional lifestyles with modern high-income societies to explain rising cancer rates. Processed foods, low activity, chronic stress, and chemical exposure are presented as a harmful metabolic environment.
Mitochondria-centered prevention
His prevention message is to protect mitochondrial function through sleep, exercise, reduced stress, and less processed food. He frames these habits as a general defense against cancer and other chronic diseases.
Prevention and risk zones
He describes GKI zones that range from prevention to high risk. Lower glucose with modest ketones is framed as a favorable state, while chronically high glucose and low ketones signal metabolic danger.
Ketosis and metabolic therapy
He argues nutritional ketosis can help normal cells while stressing cancer cells that cannot efficiently use ketones. In his model, this weakens tumors without harming healthy tissue.
Need to target glutamine too
He says lowering glucose alone is not enough because tumors can still rely on glutamine. Effective management, in his view, requires combining metabolic therapy with methods that also suppress glutamine use.
Combining metabolism with standard care
Rather than rejecting chemotherapy entirely, he argues for using it differently. He says ketosis may allow lower doses, better tumor sensitivity, and less damage to healthy cells.
Metastasis and hybrid cells
On tumor spread, he highlights macrophage tumor cell hybrids as a possible explanation for metastasis. He suggests these mobile cells are also vulnerable to metabolic strategies targeting glucose and glutamine.
Fasting and fasting-mimicking approaches
He discusses fasting, intermittent fasting, and fasting-mimicking diets as ways to lower glucose and shift metabolism. These approaches are presented as tools that may improve the effectiveness of treatment.
Hyperbaric oxygen synergy
He describes hyperbaric oxygen as a way to increase oxidative stress selectively in metabolically weak cancer cells. Combined with ketosis, he says it may slow tumor growth more effectively.
Concerns about cachexia and keto
He addresses the fear that ketogenic diets may worsen cachexia in cancer patients. His distinction is that therapeutic weight loss differs from pathological wasting, though he stresses physician oversight and comorbidities matter.
Environmental toxins and policy ideas
He links microplastics, forever chemicals, pesticides, and contaminated water to mitochondrial damage. On prevention, he favors education, better food access, less ultra-processed food, exercise, stress reduction, and cleaner environments.
Patient self-advocacy
For patients and families, he encourages learning the metabolic framework and discussing it with clinicians. He portrays metabolic therapy as a patient-empowering approach that can complement medical care.
Hope through longer-term management
His central promise is not guaranteed cure but longer survival with better quality of life. He points to case reports and clinical collaborations as evidence that some patients may live substantially longer.